RhumbLine Advisers
CAPR icon

RhumbLine Advisers’s Capricor Therapeutics CAPR Stock Holding History

RhumbLine Advisers’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.58M Buy
52,083
+5,106
+11% +$136K ﹤0.01% 1977
2025
Q4 		$1.36M Sell
46,977
-3,902
-8% -$51K ﹤0.01% 2070
2025
Q3 		$367K Sell
50,879
-2,571
-5% -$18.9K ﹤0.01% 2883
2025
Q2 		$531K Buy
53,450
+3,636
+7% +$38.4K ﹤0.01% 2653
2025
Q1 		$473K Buy
49,814
+3,731
+8% +$51.8K ﹤0.01% 2613
2024
Q4 		$636K Buy
46,083
+14,169
+44% +$248K ﹤0.01% 2514
2024
Q3 		$485K Buy
31,914
+1,028
+3% +$5.08K ﹤0.01% 2714
2024
Q2 		$147K Buy
+30,886
New +$172K ﹤0.01% 3386

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return